Gilead Sciences, who is the patent holder of the medication, has the total information about the pre-clinical and clinical examinations for remdesivir, sources said. US pharma mammoth Gilead Sciences has applied to India’s medication controller looking for showcasing authorisation for its enemy of viral medication remdesivir, which is being touted as a potential treatment for […]